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Abstract
Background: Surgery for chronic pulmonary aspergillosis is often technically risky. The choice of immediate
thoracoplasty or muscle flap plombage to prevent postoperative space problems remains controversial. This study
focused on the use of muscle flaps to prevent postoperative complications.
Methods: During an 8-year period (2004 to 2012), all patients surgically treated for chronic pulmonary aspergillosis
were enrolled in this retrospective study. Concomitant intrathoracic transposition of the latissimus dorsi muscle flap
has been performed since 2011. The clinical records of these patients were reviewed retrospectively.
Results: From 2004 to 2012, 16 patients were treated for chronic pulmonary aspergillosis. Fifteen patients received
lobectomies and one had a partial resection. A preventive latissimus dorsi muscle flap was used in 6 patients (37 %).
No postoperative deaths occurred. Prolonged air leaks appeared in 2 patients without muscle flaps, resulting in
empyema in both. None of the patients with preventive muscle flaps suffered prolonged air leaks and subsequent
empyema. In the outpatient clinic, late onset air leaks developed in 2 patients, one of whom had a lobectomy with
muscle flap while the other had a lobectomy without muscle flap. Residual pleural space persisted in these two
patients and Aspergillus infection later recurred.
Conclusions: Concomitant latissimus dorsi muscle flaps may be effective for the prevention of prolonged air leaks
and subsequent empyema. Late onset air leaks are problematic.
Keywords: Pulmonary aspergillosis, Surgical treatment, Hemoptysis, Muscle flap, Empyema, Bronchial artery
embolization
Background
Surgery for chronic pulmonary aspergillosis is often
technically hazardous, resulting in a complicated post-
operative outcome [1–3]. Chronic pulmonary aspergil-
losis may occur following a pulmonary insult such as
tuberculosis, sarcoidosis, or pneumothorax [1, 2, 4].
The presence of hemoptysis is the most commonly
used indicator of the need for surgery due to the risk of
massive and fatal blood loss [1, 5]. Up to 30 % of pa-
tients with minor hemoptysis may subsequently have
life-threatening hemoptysis [1, 2, 6]. Dense adhesion,
pleural thickening, and incomplete re-expansion of
residual lung parenchyma have resulted in mortality
rates of up to 43 % and morbidity rates of up to 60 %,
characterized by hemorrhage, residual pleural space,
bronchopleural fistula, and empyema [1, 7]. The decline
of tuberculosis has led to a dramatic reduction in both
mortality and morbidity [1, 8–10], but surgical risk re-
mains an issue in complex cases. Surgical treatment has
been helpful not only in reducing symptoms but also in
prolonging the survival of patients, including those who
are asymptomatic [7, 8, 11]. The overall 10-year sur-
vival of surgically treated patients (84.8 %) is signifi-
cantly better than the survival of medically treated
patients (56.7 %), even in patients without symptoms
(82.5 % vs 50.5 %) [7]. Our institute recently introduced
the use of a primary latissimus dorsi muscle flap to
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prevent prolonged air leaks that result in postoperative
pyothorax. In cases with life-threatening hemoptysis,
bronchial artery embolization was performed first as a
temporizing measure, and non-emergency surgical
treatment was planned. Here we report the results of a
retrospective study on the surgical treatment of chronic
pulmonary aspergillosis, with specific attention on the
use of a preventive latissimus dorsi muscle flap.
Methods
During an 8-year period (2004 to 2012), all patients
surgically treated for chronic pulmonary aspergillosis in
our institution were enrolled in this retrospective study.
The clinical records of these patients were reviewed
retrospectively for clinical presentation, underlying dis-
ease, preoperative treatment such as anti-fungal therapy
or bronchial artery embolization, indications for surgery,
surgical procedures performed, postoperative mortality,
complications, and long-term follow-up status. A diag-
nosis of chronic pulmonary aspergillosis was made on
the basis of clinical symptoms, radiologic findings and
serological examination, such as serum Aspergillus pre-
cipitating tests or serum beta-D glucan testing. Patients
were classified as having simple or complex aspergilloma
on the basis of medical imaging and operative findings:
simple aspergilloma was defined as a thin-wall cavitation
occurring in an otherwise healthy lung, while complex
aspergilloma was found either in a thick-walled cavita-
tion or in the presence of severe underlying parenchymal
or pleural sequelae [5, 12]. Aspergillomas and Aspergil-
lus organisms were histologically confirmed on all
resected specimens.
We selected patients for surgery if they presented with
aspergilloma or unstable symptoms after antifungal ther-
apy with micafungin or voriconazole. Since 2008, bron-
chial artery embolization is performed first for patients
with hemoptysis, and elective surgery is planned there-
after. Since 2011, concomitant intrathoracic transpos-
ition of the latissimus dorsi muscle flap has been
performed, including one case with primary thoraco-
plasty. The Institutional Review Board of our institution
approved this retrospective study of surgical treatment
for chronic pulmonary aspergillosis (#25–39).
The Pearson chi-square test or Fisher exact test was
used to compare categorical and dichotomous variables.
Analysis of variance with life tables and Kaplan-Meier
curves were used for the analyses of overall survival.
Differences between two groups were analyzed using
the log-rank test. Statistical significance was assumed
to exist at two-tailed p values less than 0.05. All statis-
tical analyses were performed using a statistical soft-
ware package (JMP, version 11.0; SAS Institute, Cary,
NC, USA).
Results
Clinical characteristics and underlying disease
From 2004 to 2012, of 62 patients diagnosed with chronic
pulmonary aspergillosis, 16 were surgically treated for
chronic pulmonary aspergillosis at our institution. The
study group consisted of 14 male patients and 2 female
patients with a mean age of 65 years (range 50–78). Pa-
tients with pulmonary aspergillosis had a variety of under-
lying lung diseases. Only 3 patients had no known
underlying lung disease (Table 1). Tuberculosis was the
most frequent underlying disease (56 %), followed by
chronic obstructive pulmonary disease (COPD) (38 %)
and pneumothorax (19 %). Comorbidities other than lung
disease were found in all 16 patients. Diabetes mellitus
was the most frequent comorbidity (63 %). Each patient
had at least one of the following diseases: tuberculosis,
COPD or diabetes mellitus. None of the patients had hu-
man immunodeficiency virus infection.
The mean Body Mass Index (BMI) of the group was
18.9 (range, 12.3 to 25.6). Six patients (38 %) were classi-
fied as underweight (BMI < 18.5) and 3 patients (19 %)
were categorized as severely thin (BMI < 16.0). The
mean Smoking Index was 31 pack-years (range, 10 to
100) among 12 smokers (75 %). The mean size of the
fungus ball was measured as 3.4 cm (range, 1.5 to
6.1 cm). One patient (6 %) had simple aspergilloma and
15 patients (94 %) had complex aspergillomas. Lesions
were located in the right upper lobe in 10 patients and
in the left upper lobe in 6 patients. There were no statis-
tically significant differences in patient characteristics
between the group surgically treated with muscle flaps
(n = 6) and without muscle flaps (n = 10, Table 1).
Symptoms and preoperative treatment
Seven patients (44 %) were free of symptoms, but dem-
onstrated radiological lesions with fungus balls. Surgical
treatment was chosen for the remaining 9 patients be-
cause of massive hemoptysis in 6 patients (38 %), minor
hemoptysis in 2 patients (13 %) and pneumothorax in
one patient (6 %). Previous antifungal therapy had been
administered to 15 patients (94 %). The median interval
from initial presentation to surgery was 8.2 months
(range, 0.5 to 127.9 months).
Preoperative embolization was performed for 4 pa-
tients with massive hemoptysis, 2 patients with minor
hemoptysis and 3 asymptomatic patients. It was success-
ful for 5 of the 6 patients (83 %) with massive or minor
hemoptysis. Embolization for the 3 asymptomatic pa-
tients was performed to reduce intraoperative blood loss.
The median interval from preoperative embolization to
surgery was 6.0 days (range, 1 to 21 days). Fifteen surgi-
cal procedures (94 %) were planned as elective surgeries;
emergency surgery was performed for only one of the
patients with pneumothorax.
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Surgical procedures
Lobectomies were performed through posterolateral
thoracotomies in 15 patients with complex aspergillo-
mas, and partial resection through axilla thoracotomy in
one patient with simple aspergilloma. After 2011,
concomitant intrathoracic transposition of latissimus
dorsi muscle flap was performed in 6 patients (38 %), in-
cluding one patient with primary thoracoplasty resulting
from a large residual pleural space. The mean operative
time was 323 min (range, 93 to 625 min). Operative time
was longer for patients with muscle flaps (mean
406 min, range, 315 to 625 min) than for patients with-
out muscle flaps (mean 273 min, range, 93 to 392 min,
p = 0.023, t-test, Table 3). Mean intraoperative blood loss
was 725 mL (range, trace to 2225 mL). There was no
statistical difference between patients with muscle flaps
(mean 1017 mL, range, 381 to 2225 mL) and those
without muscle flaps (mean 550 mL, range, trace to
1500 mL, p = 0.140, t-test, Table 3). There was no statis-
tical difference between patients with preoperative
embolization (mean 903 mL, range, 180 to 2225 mL)
and those without preoperative embolization (mean
497 mL, range, trace to 1500 mL, p = 0.192, t-test).
Intraoperative spillage occurred in two patients (Cases
4 and 5 in Table 2). Massive irrigation was performed
(6 L and 10 L, respectively) and postoperative antifungal
therapy was continued. One patient suffered late onset
air leak and recurrent aspergillus infection 22 months
following surgery. The other remained free from recur-
rence 25 months after surgery.
Postoperative mortality and complications
No postoperative deaths occurred within 30 days. While
the postoperative courses of 12 patients (75 %) were un-
eventful, postoperative nonfatal complications occurred in
4 patients (25 %) (Table 2). Prolonged air leaks developed
in 2 patients who had either a lobectomy without the
muscle flap or underwent partial resection, resulting in
empyema in both. Open window thoracostomy was per-
formed on one patient, and thoracoplasty on the other pa-
tient. None of the patients with the preventive latissimus
dorsi muscle flap suffered prolonged air leaks and subse-
quent empyema. While two patients required home oxy-
gen therapy at discharge, all patients were discharged to
their homes. No occurrences of postoperative excessive
bleeding or bronchial fistula were found. Length of stay in
Table 1 Patient clinical characteristics
Variable Total With flap Without flap p
Age (years), mean ± SD 65 ± 8 65 ± 7 66 ± 9 0.824
Sex (Male/Female) 14/2 6/0 8/2 0.500
Smoking status (Current/Former/Never) 10/2/4 3/0/3 7/2/1 0.108
Smoking index (pack-year), mean ± SD 31 ± 26 18 ± 20 39 ± 27 0.130
Body mass index (<18.5/≥ 18.5) 6/10 3/3 3/7 0.607
Performance status (0/1/2/3) 13/1/2/0 4/1/1 9/0/1 0.309
Underlying lung disorders (Tbc/others/none) 9/4/3 3/1/2 6/3/1 0.498
Tuberculosis 9 3 6
Chronic obstructive pulmonary disease 6 1 5
Pneumothorax 3 1 2
Idiopathic pulmonary fibrosis 1 0 1
Lung cancer 1 1 0
None 3 2 1
Comorbidity (diabetes mellitus/others) 10/6 4/2 6/4 1.000
Diabetes mellitus 10 4 6
Chronic renal failure 2 1 1
Othersa 5 2 3
None 0 0 0
Location; RUL/LUL 10/6 3/3 7/3 0.607
Size of fungus ball (cm), mean ± SD 3.4 ± 1.4 3.9 ± 1.9 3.1 ± 1.1 0.262
Type of aspergilloma (simple/complex) 1/15 6/0 9/1 1.000
Preoperative antifungal therapy 13/3 6/0 7/3 0.250
Preoperative bronchial artery embolization 9/7 4/2 5/5 0.633
SD standard deviation; aOthers = liver cirrhosis, ulcerative colitis with steroid use, Marfan syndrome, dilated cardiomyopathy, and gastric cancer
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the intensive care unit was 2 days for most patients. One
patient did not stay in the intensive care unit, and one pa-
tient stayed 3 days. The mean length of hospitalization
after surgery was 22 days (range: 7 to 72 days). There was
no statistically significant difference in postoperative com-
plications between the two patient groups surgically
treated with or without a muscle flap (Table 3).
Long-term outcomes
In the outpatient clinic, late onset air leaks were found in
2 patients who had received lobectomies, with and
without a muscle flap. Two and three months after the
surgery, intrathoracic fluid levels decreased with no aspir-
ation pneumonia on chest radiographs. Although no fur-
ther surgical intervention was required and the patients
were clinically stable, residual pleural space persisted and
Aspergillus infection recurred 8 and 15 months later. One
patient declined 24 months after the surgery; the other is
alive and well 92 months after the surgery. Two patients
suffered pneumonia and were readmitted, and one of
them declined 5 weeks after the surgery. The remaining
five patients died from malignant disease (n = 2), gastric
Table 2 Surgical procedures and postoperative clinical courses
No. Age Surgical Blood Loss Complication Hospital
/sex Procedure (mL) (in hospital) (after discharge) staya (days)
1 60 Lobectomy 381 Respiratory failure (requiring home
oxygen therapy at discharge)
Pneumonia 16
/m with MF + TP
2 61 Lobectomy 940 - 20
/m with MF
3 74 Lobectomy 457 - 16
/m with MF
4 69 Lobectomy 2225 - 10
/m with MF
5 55 Lobectomy 1491 - Late onset air leak 14
/m with MF + Recurrence
6 68 Lobectomy 608 - 31
/m With MF
7 56 Lobectomy 1500 - Late onset air leak 18
/f + Recurrence
8 58 Lobectomy 651 - 10
/m
9 71 Lobectomy 715 - 16
/m
10 75 Lobectomy 132 - 8
/m
11 61 Lobectomy 240 - 10
/m
12 67 Lobectomy 855 Respiratory failure (requiring home oxygen 58
/f therapy at discharge)
13 64 Lobectomy 180 - 7
/m
14 75 Lobectomy 1021 Prolonged air leak 72
/m Empyema
15 78 Lobectomy 210 - Pneumonia 30
/m
16 50 Partial resection trace Prolonged air leak 31
/m Empyema
m male, f female, MF muscle flap, TP thoracoplasty, aHospitalization stay length following surgery
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perforation (n = 1), and unknown causes (n = 2). The 3-
year overall survival following surgery was 63 %. There
was no significant difference in the 3-year overall survival
rates between patients with a muscle flap (31 %) and pa-
tients without a muscle flap (79 %, p = 0.242, log-rank test,
Fig. 1).
Discussion
We selected patients with chronic aspergillosis for
surgery when they presented with aspergilloma or un-
stable conditions such as hemoptysis after antifungal
therapy. For patients with hemoptysis, bronchial artery
embolization is performed first and elective surgery is
planned thereafter. For patients with complex aspergil-
loma, who were supposed to have tight adhesions,
potential risk for incomplete re-expansions and postop-
erative persistent air leakage, concomitant intrathoracic
transposition of the latissimus dorsi muscle flap was
considered. Since full posterolateral thoracotomies were
usually performed because of tight adhesion or invasion
of a cavitary lesion into the chest wall, the latissimus
dorsi was often cut and not available for potential use in
a second surgery [3, 11]. While Daly et al. [13] have rec-
ommended sparing the latissimus dorsi muscle for po-
tential use, such an approach can hinder the operative
field of the first surgery [10]. Harvesting the latissimus
dorsi muscle flap at the full posterolateral thoracotomy,
instead of cutting or sparing it, and covering the bron-
chial stump and the cutting surface of the residual lung
parenchyma was performed to prevent prolonged air
leakage and consequent empyema, although we could
not demonstrate the benefit statistically because of the
small sample size. Patients with muscle flaps required
longer operative time and experienced slightly more
blood loss than patients without muscle flaps, but the
differences should reflect the difficulty of the surgery.
The procedure of harvesting and transposition of the
latissimus dorsi muscle flap usually requires approxi-
mately 30 min without significant blood loss.
Incomplete reexpansions after lung resections are fre-
quent and responsible for severe complications following
surgery for chronic pulmonary aspergillosis [5]. Pleural
space problems can manifest as prolonged air leaks, re-
sidual pleural pocket, and Aspergillus empyema [3]. Before
introduction of the latissimus dorsi muscle flap, 2 patients
developed prolonged air leaks, which progressed into em-
pyema requiring thoracoplasty in one patient and open
window thoracostomy in the other. Prevention of pro-
longed air leaks is essential for the deterrence of postoper-
ative empyema.
The use of immediate thoracoplasty versus muscle flap
plombage to prevent postoperative space problems is still
an issue of debate. Massard et al. [3] prefer to use thoraco-
plasty as a second choice procedure to avoid unnecessary
mutilation of some patients. They use the preventive im-
mediate thoracoplasty reported by Personne et al. in up to
25 % of their cases [3]. Akbari et al. [9] and Kim et al. [11]
do not employ primary thoracoplasty or latissimus dorsi
muscle flaps. Park and Jheon [10], Endo et al. [14, 15] and
Babatashi et al. [16] perform concomitant thoracoplasty in
some cases to prevent space problems, and the possible
development of empyema, if a large volume of dead space
is encountered. Chen et al. [17] use additional surgical
procedures such as pleural tenting and partial thoraco-
plasty to avoid prolonged air leaks or residual space,
sometimes clamping the phrenic nerve to induce tempor-
ary paralysis in patients with good lung function. Farid
et al. [18] have reported that persistent space problems
might be addressed with a pectoralis flap, modest thoraco-
plasty, or both, and that the use of a muscle flap reduces
the extent of a thoracoplasty, which is helpful for later
functioning of the chest.
The late effect of the muscle flap is another concern.
Farid et al. [18] explained that initially the muscle flap
Table 3 Surgical procedures and postoperative morbidities
Variable Total With flap Without flap p
Surgical procedure (Lobectomy/Partial resection) 15/1 6/0 9/1 1.000
Operative time (minutes), mean ± SD 323 ± 118 406 ± 114 273 ± 92 0.023
Blood loss (mL), mean ± SD 725 ± 604 1017 ± 718 550 ± 481 0.140
Complication in hospital 4/12 1/5 3/7 1.000
Respiratory failure 2/14 1/5 1/9 1.000
(requiring home oxygen therapy at discharge)
Prolonged air leak & empyema 2/13 0/6 2/7 0.486
Complication after discharge 3/13 2/4 1/9 0.518
Pneumonia 1/15 1/5 0/10 0.375
Late onset air leak + Recurrence 2/14 1/5 1/9 1.000
Hospital staya (days), mean ± SD 22 ± 18 17 ± 7 26 ± 22 0.408
aHospitalization stay length after the surgery
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will often nearly fill the cavity and then atrophy, leaving
considerable space. Chest x-rays showed findings of a
small finger of muscle, which were believed to be suffi-
cient to keep Aspergillus from recolonising the cavity
[18]. In our series, although the muscle flap was effective
for preventing postoperative persistent air leakage in all
cases, one case developed late onset air leakage resulting
in persistent space and recurrence of Aspergillus infec-
tion. Late onset air leakage has also occurred among pa-
tients without a preventive muscle flap and resulted in
recurrence of Aspergillus infection, probably accompan-
ied by pleural aspergillosis. Late onset air leakage and
subsequent persistent pleural space would be a possible
risk for recurrent Aspergillus infections.
While recurrent hemoptysis or Aspergillus infection fol-
lowing surgery is reportedly rare [5, 8, 9, 19], Farid et al.
[18] found that 8 out of 30 patients (26 %) experienced
disease recurrence (Table 4). Although the difference is
not obvious, Farid et al. [18] discussed how their postoper-
ative follow-up protocol was formulated to enable early
detection of recurrent disease, but concluded that recur-
rence is problematic. In our institute, 2 of 16 patients
(13 %) with late onset persistent air leakage and subse-
quent pleural space have developed recurrent Aspergillus
infection. One patient declined 24 months after surgery.
Regarding the extent of resection, anatomical lobec-
tomy might be suitable for inflammatory disease, if the
residual lung function permits. Chen et al. [17] preferred
complete lobectomy to avoid possible complications and
recurrence, with only 2 of 256 cases of postoperative
fungal relapse: one patient after a wedge resection by
video-assisted thoracic surgery and another after a lob-
ectomy combined with a segmentectomy. Although it is
desirable to limit resection as much as possible, to pre-
vent a decrease in lung function [20], a radical resection
of affected areas most effectively improves patient out-
come [17] and minimizes the risk of postoperative pro-
longed air leakage. Although division of interlobar
fissures using electrocautery has been used to reduce the
residual lung volume caused by stapling [10], the poten-
tial risk for prolonged air leakage should be considered
in cases with incomplete reexpansion of the residual
lung.
Preoperative bronchial artery embolization for
hemoptysis was successful in 5 out of 6 patients (83 %)
in our series, allowing immediate cessation of life
threatening hemoptysis. Non-emergency surgical treat-
ment was then planned to proceed within two weeks.
This modality has been used as a temporizing measure
and not with permanent intent [5, 9, 10, 13, 18]. While
the control of bleeding has been achieved in more than
90 % of cases [21], recurrent fatal hemoptysis has been
Fig. 1 The 3-year overall survival following surgery
Table 4 Recent literature concerning surgically treated chronic pulmonary aspergillosis
Author Published year n Mortality Morbidity Air leak Empyema Recurrence
Babatasi [15] 2000 84 4 % 69 % 37 % 6 % 0 %
Regnard [5] 2000 89 6 % 42 % 10 % 8 % 0 %
Endo [14] 2001 10 0 % 40 % ND 10 % 10 %
Park [10] 2002 110 1 % 24 % ND 12 % 0 %
Kim [11] 2005 88 1 % 27 % 13 % 2 % 5 %
Akbari [9] 2005 60 2 % 33 % 7 % 7 % 0 %
Brik [23] 2008 42 2 % 29 % 2 % 7 % 0 %
Lee [7] 2009 135 4 % 30 % 10 % 2 % 4 %
Lejay [8] 2011 33 0 % 12 % 9 % 3 % ND
Chen [16] 2012 256 1 % 16 % 3 % 1 % 1 %
Farid [17] 2013 30 0 % ND 23 % 20 % 26 %
Present cases 16 0 % 25 % 19 % 13 % 13 %
(with MF) (6) (0 %) (17 %) (0 %) (0 %) (17 %)
MF muscle flap, ND not described
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reported in the weeks following embolization [22] or
30-50 % in 3 years [21]. Long delays before surgery are
not recommended [5].
Farid et al. [17] reported pre-operative percutaneous
endoscopic gastrostomy feeding as another method of
preoperative stabilization. Major surgical procedures re-
quire sufficient nutritional and performance status [15].
The survival of patients with preoperative weight loss
exceeding 10 % of their usual body weight was signifi-
cantly diminished, with a 5-year actuarial survival rate of
only 30 % [5].
This study had several limitations. First, it was a retro-
spective analysis covering an 8-year period. Second, we
could not confirm any statistically significant differences
because of the small number of patients. However, we
believe this study may provide some useful information
for the surgical management of patients with chronic
pulmonary aspergillosis.
Conclusions
In conclusion, concomitant latissimus dorsi muscle flaps
may be effective for prevention of prolonged air leaks
and subsequent empyema, while late onset air leakage
resulting in residual pleural space and recurrent Asper-
gillus infection were problematic. Surgical management
remains the mainstay of treatment for aspergilloma.
With preoperative stabilization using bronchial arterial
embolization, early surgical intervention on a non-
emergency basis is recommended.
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